Fundraising Fox
Acclaro
Founded 2018 · 127 employees on LinkedIn · 1 known investors
Find your way into Acclaro
Sign up to find every way you can get introduced to Acclaro
- Your email: who you already know at Acclaro, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Acclaro team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Acclaro develops UltraClear, an aesthetic laser platform using proprietary 2910 nm cold ablative fiber laser technology with seven treatment modules in one device for skin rejuvenation, addressing photodamage, wrinkles, acne scars, pigmentation, and laser-enabled surgical procedures. The device is sold to physicians and aesthetic practices for treating patients across all skin types.
Investors · 1
Frequently asked questions
- What does Acclaro do?
- Acclaro develops UltraClear, an aesthetic laser platform using proprietary 2910 nm cold ablative fiber laser technology with seven treatment modules in one device for skin rejuvenation, addressing photodamage, wrinkles, acne scars, pigmentation, and laser-enabled surgical procedures. The device is sold to physicians and aesthetic practices for treating patients across all skin types.
- Who are Acclaro's investors?
- Acclaro's investors include Accelmed Partners.